A study of prucalopride in gastroesophageal reflux disease patients affected with Ineffective esophageal motility.

Trial Profile

A study of prucalopride in gastroesophageal reflux disease patients affected with Ineffective esophageal motility.

Completed
Phase of Trial: Phase IV

Latest Information Update: 01 Nov 2017

At a glance

  • Drugs Prucalopride (Primary)
  • Indications Gastro-oesophageal reflux; Gastrointestinal motility disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2017 Results presented at the 25th United European Gastroenterology Week
    • 15 Sep 2017 New trial record
    • 12 Sep 2017 Results (n=7) published in the Journal of Gastroenterology and Hepatology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top